C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) C07K 14/435 (2006.01) C07K 14/47 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2304124
The present invention relates generally to novel molecules capable of, inter alia, modulating apoptosis in mammalian cells and to genetic sequences encoding same. More particularly, the present invention relates to a novel member of the Bcl-2 family of proteins, referred to herein as "Bim", and to genetic sequences encoding same. The molecules of the present invention are useful, for example, in therapy, diagnosis, antibody generation and as a screening tool for therapeutic agents capable of modulating physiological cell death or survival and/or modulating cell cycle entry.
De manière générale, l'invention concerne de nouvelles molécules, capables notamment de moduler l'apoptose des cellules de mammifères, et des séquences génétiques codant pour lesdites molécules. Plus particulièrement, elle concerne un nouveau membre de la famille BCL-2 des protéines, dénommé ici "Bim", et des séquences génétiques codant pour ladite protéine. Les molécules de la présente invention sont utiles, par exemple, pour le traitement, le diagnostic et la production d'anticorps, ainsi que comme agent de criblage pour des agents thérapeutiques capables de moduler la mort physiologique ou la survie des cellules et/ou de moduler leur entrée dans le cycle cellulaire.
Adams Jerry
Cory Suzanne
Huang David C. S.
O'connor Liam
O'reilly Lorraine
Ridout & Maybee Llp
The Walter And Eliza Hall Institute Of Medical Research
LandOfFree
Bci-2-like protein bim and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bci-2-like protein bim and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bci-2-like protein bim and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1812235